ASX Weekly Roundup — 11 May to 15 May 2026
Weekly summary of the most significant bullish and bearish ASX announcements for the week of 11 May to 15 May 2026, focusing on shorted stocks.
It was a week of starkly contrasting realities on the ASX, defined by a heavy tilt toward regulatory scrutiny and fundamental shifts in corporate guidance. While some players enjoyed the windfall of successful takeovers or much-needed cash injections, others faced the sobering reality of management missteps and legal liabilities. For the retail investor—and particularly those watching short interest closely—the week provided a masterclass in how sudden shifts in sentiment can turn a position from a strategic bet into a volatile headache.
Bullish Signals
ASX:ALK — Alkane Resources Ltd
Alkane Resources has delivered a knockout performance for the third quarter, reporting a massive $93 million net profit. With gold and antimony production hitting record levels of 44,669 oz and 377 tonnes respectively, the company is clearly reaping the rewards of high commodity prices following its merger with Mandalay Resources. This isn't just a paper profit; the company is sitting on a robust liquidity cushion of $374 million across cash, bullion, and investments.
From a short-seller's perspective, this announcement is a significant hurdle. With a current short interest of just 0.76%, there isn't a massive "squeeze" waiting to happen, but the sheer strength of the balance sheet makes it difficult for bears to argue that the company lacks the capital to fund future growth. The high conversion of earnings to cash ($161 million in EBITDA and operating cash) suggests that the company's operational execution is top-tier. For those who were shorting based on fears of post-merger integration friction or liquidity concerns, these results serve as a firm rebuttal. The question now is whether the company can maintain these high margins if commodity prices soften in the second half of the year.
ASX:WR1 — Winsome Resources
The path to certainty has finally been cleared for Winsome Resources. Following the Supreme Court of WA's approval of the Share and Option Schemes, the acquisition by Li-FT Power Ltd is moving into its final stages. With ASIC lodgement expected on 12 May, the schemes become legally effective, leading to a requested trading suspension. This represents the successful conclusion of a takeover process that provides immediate clarity for shareholders.
With a negligible short interest of 0.01%, there is essentially no bearish appetite left in the stock, which makes sense given that the deal is effectively done. For investors, this is a "liquidity event" rather than a trading play; the focus shifts entirely to the exit price at the agreed scheme level. This announcement effectively removes all speculative volatility from the equation, leaving nothing for short sellers to target but a clean exit.
ASX:CU6 — Clarity Pharmaceuticals
Clarity Pharmaceuticals has secured a much-needed $9.8 million liquidity boost via an R&D tax incentive refund. This non-dilutive capital injection is a strategic win, as it allows the company to fund its Targeted Copper Theranostic (TCT) platform without immediately tapping the equity markets and diluting existing shareholders. While the company is in a capital-intensive phase of clinical development, this $9.76 million windfall extends the cash runway significantly.
The short interest in CU6 stands at 8.26%, which is the highest among this week's positive movers. This suggests that a segment of the market was likely betting against the company's ability to fund its pipeline or perhaps questioning the speed of its clinical progress. However, this infusion of cash provides a significant buffer that could catch short sellers off guard if clinical data from the SAR-bisPSMA or SARTATE trials comes in stronger than expected. For those shorting the stock, the "cash runway" argument just got a lot more convincing, potentially turning a speculative short into a squeeze-risk if the stock price begins to climb on clinical optimism.
Bearish Signals
ASX:RSG — Resolute Mining
In one of the more embarrassing turns for a mining house this week, Resolute Mining had to issue a formal retraction of its ABC Project Scoping Study just one day after its initial release. The company admitted that the study was fundamentally flawed because it relied on 100% "inferred" resources to set production targets—a major breach of ASX Listing Rule 5.16 regarding a reasonable basis for statements. This kind of regulatory fallout is a nightmare for management, as it effectively wipes out the growth narrative they attempted to build.
For anyone holding a short position, this is a clear vindication of the bear case: the project's economics were built on shaky geological ground. The stock now faces a period of deep skepticism as investors wait for a revised, much more conservative study that uses higher-confidence resource categories. The immediate impact is a loss of credibility and a likely downward re-rating as the market adjusts to the reality that the "attractive economics" might not exist once the data is properly vetted.
ASX:CSL — CSL Limited
The heavy hitter of the ASX, CSL, delivered some sobering news following a 90-day review by Interim CEO Gordon Naylor. The company has revised its FY26 guidance downward, projecting revenue of $15.2 billion and NPATA of $3.1 billion. The headwinds are multifaceted: a $300 million hit in the U.S. Immunoglobulin segment due to inventory shifts, a $200 million drag from the Chinese Albumin market, and another $150 million loss due to geopolitical volatility and competition.
With a low short interest of only 0.61%, CSL is not a typical "short target," but this guidance revision will undoubtedly trigger selling pressure from institutional investors. The bear case here is centered on the "timing" of growth; management admitted that financial benefits from their transformation program will take longer to materialise than previously thought. For investors, the question is whether this is a temporary dip or a fundamental shift in CSL's growth trajectory. Shorts might find themselves under pressure if the restructuring efforts deliver cost efficiencies faster than expected, but for now, the momentum is decidedly bearish.
ASX:FMG — Fortescue Ltd
Fortescue has hit a significant legal roadblock following a Federal Court ruling regarding the Yindjibarndi matter. The court found Fortescue liable for Native Title compensation, resulting in a substantial $150 million determination for cultural loss, alongside an additional A$100,000 plus interest for economic loss. While the direct cash outflow is a one-off, the scale of the cultural loss settlement is significant and serves as a stern reminder of the legal complexities inherent in large-scale mining operations.
The short interest on FMG is currently at 2.59%. While the $150 million hit might not break the balance sheet of a giant like Fortescue, it introduces a new layer of political and legal risk that bears will be quick to exploit. The market is now looking to see if this ruling sets a precedent that could lead to similar claims across Fortescue’s other operational footprint. For shorts, the bear case is built on the increasing cost of "social license" and the potential for mounting legal liabilities that could weigh on long-term valuations.
The Week Ahead
As we move into next week, the market's focus will likely shift from these sudden corporate shocks to the broader macroeconomic environment. We should keep a close eye on whether the volatility seen in companies like Resolute and CSL leads to a wider bout of investor caution across the resource sector. Watch for any further updates on the effective date of the Winsome takeover, as that will mark the end of one chapter and the beginning of another.